Welcome to This Week in Rheumatology. This week we're covering 10 notable papers spanning predicting and preventing disease progression in psoriatic arthritis, cardiorenal management in systemic autoimmune diseases, and novel clinical tools for patient phenotyping and care delivery. Let's dive in.

This week's papers:

1. Progression from oligoarticular to polyarticular psoriatic arthritis and apremilast as a disease modifier: novel insights from FOREMOST. — Rheumatology (Oxford, England) 2026
2. Are RAS inhibitors necessary during intensive immunosuppression for lupus nephritis? Real-world evidence from the STAR cohort. — Lupus science & medicine 2026
3. Radiographic Sacroiliitis Progression in Psoriatic Arthritis. — Rheumatology (Oxford, England) 2026
4. Use of advanced cardiovascular imaging in rheumatic immune-mediated inflammatory diseases. — Rheumatology (Oxford, England) 2026
5. Stability and prognostic value of B-cell markers in primary Sjögren's syndrome: results from the French ASSESS cohort. — Rheumatology (Oxford, England) 2026
6. Clustering-based stratification of fibromyalgia subtypes: A comparative analysis of medicated and non-medicated cohorts from two academic centers. — Seminars in arthritis and rheumatism 2026
7. Personalized, physiotherapist-guided exercise programs in juvenile idiopathic arthritis: home-based vs. immersive virtual reality (JiaFitXR). — Rheumatology (Oxford, England) 2026
8. Development and validation of a Relapsing Polychondritis disease-specific Quality of Life instrument (ERN ReCONNET RP-QoL). — Rheumatology (Oxford, England) 2026
9. Imaging techniques for assessing the hand in systemic sclerosis: a systematic review. — Seminars in arthritis and rheumatism 2026
10. Mapping inequalities in rheumatology care in Europe: the first edition of the EULAR RheumaFacts project. — Annals of the rheumatic diseases 2026

Listen at AudioScholar